These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 12538324)

  • 41. Diagnosis and treatment of Graves disease.
    Streetman DD; Khanderia U
    Ann Pharmacother; 2003; 37(7-8):1100-9. PubMed ID: 12841824
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Carbimazole-induced myositis in the treatment of Graves' disease: a complication in genetically susceptible individuals?
    Lim AY; Kek PC; Soh AW
    Singapore Med J; 2013 Jul; 54(7):e133-6. PubMed ID: 23900475
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Graves' disease in adults Antithyroid drugs, radioactive iodine, or sometimes thyroidectomy.
    Prescrire Int; 2017 Mar; 26(180):72-77. PubMed ID: 30730622
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Antithyroid drugs in the management of patients with Graves' disease: an evidence-based approach to therapeutic controversies.
    Cooper DS
    J Clin Endocrinol Metab; 2003 Aug; 88(8):3474-81. PubMed ID: 12915620
    [No Abstract]   [Full Text] [Related]  

  • 45. Evaluation and Management of Children with Thyrotoxicosis.
    Leung AKC; Leung AAC
    Recent Pat Endocr Metab Immune Drug Discov; 2017; 11(1):22-31. PubMed ID: 29589552
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Management of hyperthyroidism in children and adolescents.
    Hamburger JI
    J Clin Endocrinol Metab; 1985 May; 60(5):1019-24. PubMed ID: 2579967
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Comparative Efficacy of Four Treatments in Patients with Graves' Disease: a Network Meta-analysis.
    Ren Z; Qin L; Wang JQ; Li Y; Li J; Zhang RG
    Exp Clin Endocrinol Diabetes; 2015 May; 123(5):317-22. PubMed ID: 25988881
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Use of radioiodine in adolescent Graves' disease.
    Teelucksingh S; Singh V; Balkaran B
    Ann Trop Paediatr; 2001 Dec; 21(4):335-8. PubMed ID: 11732151
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Comparative evaluation of two fixed doses of 185 and 370 MBq 131I, for the treatment of Graves' disease resistant to antithyroid drugs.
    Esfahani AF; Kakhki VR; Fallahi B; Eftekhari M; Beiki D; Saghari M; Takavar A
    Hell J Nucl Med; 2005; 8(3):158-61. PubMed ID: 16390021
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Should radioiodine be the first-line treatment for paediatric Graves' disease?
    West JD; Cheetham TD; Dane C; Natarajan A
    J Pediatr Endocrinol Metab; 2015 Jul; 28(7-8):797-804. PubMed ID: 25719296
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Radioiodine treatment of Graves' disease - dose/response analysis.
    Cepková J; Horáček J; Vižďa J; Doležal J
    Acta Medica (Hradec Kralove); 2014; 57(2):49-55. PubMed ID: 25257150
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Remission of aplastic anemia induced by treatment for Graves disease in a pediatric patient.
    Das PK; Wherrett D; Dror Y
    Pediatr Blood Cancer; 2007 Aug; 49(2):210-2. PubMed ID: 16456859
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Follicular carcinoma of the thyroid following radioactive iodine treatment for Graves' disease.
    Staffurth JS; Holl-Allen RT
    Postgrad Med J; 1988 Nov; 64(757):878-80. PubMed ID: 3255938
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Late and transient increases in free T4 after radioiodine treatment for Graves' disease.
    Stensvold AD; Jorde R; Sundsfjord J
    J Endocrinol Invest; 1997 Nov; 20(10):580-4. PubMed ID: 9438914
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Success rate of radioiodine therapy in Graves' disease: the influence of thyrostatic medication.
    Sabri O; Zimny M; Schulz G; Schreckenberger M; Reinartz P; Willmes K; Buell U
    J Clin Endocrinol Metab; 1999 Apr; 84(4):1229-33. PubMed ID: 10199759
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Juvenile thyrotoxicosis--a South Island, New Zealand experience with long-term outcome.
    Brownlie BE; Hunt PJ; Turner JG
    N Z Med J; 2010 Apr; 123(1313):23-31. PubMed ID: 20581892
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Pediatric Graves' disease: controversies in management.
    Rivkees SA
    Horm Res Paediatr; 2010; 74(5):305-11. PubMed ID: 20924158
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Antithyroid drug treatment prior to radioiodine therapy for Graves' disease: yes or no?
    Bogazzi F; Martino E; Bartalena L
    J Endocrinol Invest; 2003 Feb; 26(2):174-6. PubMed ID: 12739747
    [No Abstract]   [Full Text] [Related]  

  • 59. Has the use of antithyroid drugs for Graves' disease become obsolete?
    Wartofsky L
    Thyroid; 1993; 3(4):335-44. PubMed ID: 7509673
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Acute pancreatitis, hepatic cholestasis, and erythema nodosum induced by carbimazole treatment for Graves' disease.
    Marazuela M; Sánchez de Paco G; Jiménez I; Carraro R; Fernández-Herrera J; Pajares JM; Gómez-Pan A
    Endocr J; 2002 Jun; 49(3):315-8. PubMed ID: 12201214
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.